MARAVAI LIFESCIENCES HOLDINGS, INC.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
Andrew Burch, previously an executive at Thermo Fisher Scientific, has joined the Company and will assume the role of Executive Vice President and General Manager of the Company’s Nucleic Acid Products Operating Division following Mr. Neel’s departure on March 31st.
Brian Neel, Chief Operating Officer, Nucleic Acid Production, of Maravai LifeSciences Holdings, Inc. (the “Company”) notified the Company of his decision to resign to pursue other interests effective March 31, 2023.
Extracted from this filing and checked against the source text.
Andrew Burch was appointed as Executive Vice President and General Manager of the Company’s Nucleic Acid Products Operating Division at MARAVAI LIFESCIENCES HOLDINGS, INC..
Andrew Burch, previously an executive at Thermo Fisher Scientific, has joined the Company and will assume the role of Executive Vice President and General Manager of the Company’s Nucleic Acid Products Operating Division following Mr. Neel’s departure on March 31st.View on SEC.gov
Brian Neel resigned as Chief Operating Officer, Nucleic Acid Production at MARAVAI LIFESCIENCES HOLDINGS, INC..
Brian Neel, Chief Operating Officer, Nucleic Acid Production, of Maravai LifeSciences Holdings, Inc. (the “Company”) notified the Company of his decision to resign to pursue other interests effective March 31, 2023.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.